IRAK4 inhibitors display synergistic activity when combined with BTK or PI3K inhibitors in B-cell lymphomas.

Drug Category: Array
Conference Category: Array
Lead Author: Vajda E, Marschke K, et al.
Published Date: 18/04/2015
Download Link: /wp-content/uploads/2019/03/IRAK%20AACR%20Poster.pdf
Download Text: Download
Popup Confirmation?:
site-sidebar-layout: default
ast-site-content-layout: default
site-content-style: default
site-sidebar-style: default
theme-transparent-header-meta: default
stick-header-meta: default
astra-migrate-meta-layouts: set
Scroll to Top